IL154417A0 - Preparation of risperidone - Google Patents

Preparation of risperidone

Info

Publication number
IL154417A0
IL154417A0 IL15441701A IL15441701A IL154417A0 IL 154417 A0 IL154417 A0 IL 154417A0 IL 15441701 A IL15441701 A IL 15441701A IL 15441701 A IL15441701 A IL 15441701A IL 154417 A0 IL154417 A0 IL 154417A0
Authority
IL
Israel
Prior art keywords
risperidone
preparation
disclosed
methods
present
Prior art date
Application number
IL15441701A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26919535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL154417(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL154417A0 publication Critical patent/IL154417A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15441701A 2000-08-14 2001-08-14 Preparation of risperidone IL154417A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22536100P 2000-08-14 2000-08-14
US24326300P 2000-10-25 2000-10-25
PCT/US2001/025387 WO2002014286A1 (en) 2000-08-14 2001-08-14 Preparation of risperidone

Publications (1)

Publication Number Publication Date
IL154417A0 true IL154417A0 (en) 2003-09-17

Family

ID=26919535

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15441701A IL154417A0 (en) 2000-08-14 2001-08-14 Preparation of risperidone
IL154417A IL154417A (en) 2000-08-14 2003-02-12 Preparation of Risperidone

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154417A IL154417A (en) 2000-08-14 2003-02-12 Preparation of Risperidone

Country Status (20)

Country Link
US (2) US6750341B2 (xx)
EP (2) EP1317434A4 (xx)
JP (3) JP3751942B2 (xx)
KR (2) KR20080028513A (xx)
AT (1) ATE401313T1 (xx)
AU (1) AU2001284880A1 (xx)
CA (1) CA2419314C (xx)
CZ (1) CZ2003668A3 (xx)
DE (1) DE60134899D1 (xx)
ES (1) ES2310410T3 (xx)
HR (1) HRP20030154B1 (xx)
HU (1) HUP0302874A2 (xx)
IL (2) IL154417A0 (xx)
IS (1) IS6713A (xx)
MX (1) MXPA03001337A (xx)
NZ (1) NZ524554A (xx)
PL (1) PL365608A1 (xx)
PT (1) PT1783118E (xx)
SK (1) SK2982003A3 (xx)
WO (1) WO2002014286A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
BR0306204A (pt) * 2002-08-30 2004-09-08 Torrent Pharmaceuticals Ltd Processo melhorado para a preparação de risperidona
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
CN100390146C (zh) 2002-11-13 2008-05-28 斯索恩有限公司 制备利培酮的方法和用于该方法的中间体
US20040180935A1 (en) * 2003-02-28 2004-09-16 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. Crystalline form Z of rabeprazole sodium and process for preparation thereof
AU2003245028A1 (en) * 2003-04-16 2004-11-04 Hetero Drugs Limited A novel crystalline form of risperidone
DK1673370T3 (da) 2003-10-16 2009-12-07 Symed Labs Ltd Krystallingsk form af linezolid
EP1711124A4 (en) * 2004-01-12 2011-06-01 Univ Pennsylvania LONG-TERM RELEASE PREPARATIONS AND METHODS OF USE THEREOF
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
ES2294494T3 (es) * 2004-04-19 2008-04-01 Symed Labs Limited Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados.
HUP0401379A3 (en) * 2004-07-08 2006-04-28 Richter Gedeon Vegyeszet Process for the preparation of risperidon
JP2008512471A (ja) * 2004-09-08 2008-04-24 ダーマトレンズ，インコーポレイティド 疎水性生体活性物質の経皮送達
HUP0402163A2 (en) * 2004-10-25 2006-05-29 Richter Gedeon Vegyeszet Process for the preparation of risperidone
US20090075974A1 (en) * 2005-04-27 2009-03-19 Umn Pharma Inc. Agent for prophylaxis and treatment of pancreatitis
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007093870A2 (en) * 2006-02-15 2007-08-23 Orchid Chemicals & Pharmaceuticals Limited A process for the preparation of risperidone
US7820816B2 (en) * 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
BRPI0811319A2 (pt) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
BRPI1007173A2 (pt) 2009-01-20 2016-02-23 Los Angeles Biomed Res Inst composição farmacêutica compreendendo ácido sórbico e benzóico e seus derivados que melhora a atividade de um neurofármaco, e seu uso, formulação farmacêutica e método de mitigação de um ou mais sintomas de um distúrbio neuropsiquiátrico
CN102786521B (zh) * 2011-05-18 2016-01-13 中国医学科学院药物研究所 利培酮晶iii型物质及制备方法与在药品和保健品中应用
CN105367570B (zh) * 2015-12-08 2017-10-10 天津市亨必达化学合成物有限公司 一种利培酮晶i型物质的制备方法
US11008277B2 (en) 2016-06-13 2021-05-18 Syneurx International (Taiwan) Corp. Co-crystals of sodium benzoate and uses thereof
RU2022101542A (ru) 2016-06-13 2022-02-03 Сайньюрекс Интернэшнл (Тайвань) Корп. Сокристаллы бензоата лития и их применения

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
ES2050069B1 (es) 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
ES2074966B1 (es) 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
AU723563B2 (en) * 1996-01-26 2000-08-31 Pharmacia & Upjohn Company Use of a combination of delavirdine and one or more protease inhibitors in HIV-1 infected patients
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
ATE264329T1 (de) 2000-05-05 2004-04-15 Rpg Life Sciences Ltd Verfahren zur herstellung von antipsychotischem 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-
US20020115672A1 (en) * 2000-08-08 2002-08-22 Barnaba Krochmal Preparation of risperidone
US20020193386A1 (en) 2002-03-28 2002-12-19 Inigo Pfeiffer Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof

Also Published As

Publication number Publication date
IL154417A (en) 2008-11-03
EP1982980A1 (en) 2008-10-22
EP1317434A1 (en) 2003-06-11
HRP20030154B1 (en) 2009-03-31
MXPA03001337A (es) 2005-06-30
US7256195B2 (en) 2007-08-14
WO2002014286A9 (en) 2003-03-27
JP2004506622A (ja) 2004-03-04
ES2310410T3 (es) 2009-01-01
KR100818875B1 (ko) 2008-04-01
CA2419314A1 (en) 2002-02-21
PT1783118E (pt) 2008-08-19
JP2008056699A (ja) 2008-03-13
CA2419314C (en) 2006-07-11
US6750341B2 (en) 2004-06-15
JP3751942B2 (ja) 2006-03-08
CZ2003668A3 (en) 2004-04-14
PL365608A1 (en) 2005-01-10
EP1317434A4 (en) 2005-06-22
ATE401313T1 (de) 2008-08-15
KR20080028513A (ko) 2008-03-31
US20040229905A1 (en) 2004-11-18
NZ524554A (en) 2005-07-29
DE60134899D1 (de) 2008-08-28
US20020115673A1 (en) 2002-08-22
IS6713A (is) 2003-02-11
HUP0302874A2 (hu) 2003-12-29
HRP20030154A2 (en) 2005-04-30
KR20030022389A (ko) 2003-03-15
AU2001284880A1 (en) 2002-02-25
SK2982003A3 (en) 2004-10-05
JP2006028192A (ja) 2006-02-02
WO2002014286A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
HRP20030154A2 (en) Preparation of risperidone
PL365683A1 (en) Selected fused pyrrolocarbazoles
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
IL145429A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0401213A3 (en) Compounds effecting glucokinase, process for their preparation and their use for production of pharmaceutical compositions
WO2000055124A3 (en) Novel compounds and compositions as protease inhibitors
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
WO2002055501A3 (en) N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
GB0003154D0 (en) Novel compounds
MY129422A (en) Medicinal compounds
HUP0400998A3 (en) Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them
PL365312A1 (en) Crystalline forms of atorvastatin
GB0004128D0 (en) Novel compounds
WO2002094774A3 (en) Oxcarbazepine dosage forms
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
WO2005063764A3 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
HUP0204563A3 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
WO2001068645A3 (en) N-cyanomethylcarboxamides and their use as protease inhibitors
WO2002076438A3 (en) Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
WO2004007441A3 (fr) Derives de 4,4' -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
YU34604A (sh) Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže
CA2535742A1 (en) Preparation of risperidone
EP1783118A3 (en) Preparation of risperidone
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
MY127289A (en) Caloporoside derivatives, process for the preparation thereof, and the use thereof